healthgenetech


Leave a comment

SureID® 21G Human STR Identification Kit makes a debut in Emirates Forensic 2017

On April 2 – 4th Health Gene Technologies visited Emirates International Forensic Conference & Exhibition Emirates Forensic 2017 – the region’s largest event on forensics and criminology at the Dubai International Convention & Exhibition Centre. The conference invited key specialists from new technology developers to criminal police judges to share international experience through workshops, exhibitions, poster presentations and oral presentations.

HGT 1

Health Gene Technologies presented an in-depth validation study of our key product – SureID® 21G Human STR Identification Kit with our scientific collaboration partner SIMEF.

HGT 2

HGT 3

 


About Health Gene Technologies

Health Gene Technologies founded in August 2011 is focused on gene analysis, molecular diagnostics product development, as well as the production and the sales of the products. HGT boasts 2,000 square meters of molecular diagnostics R&D laboratory and a 1,000 square metre GMP standard purification plant. It employs both domestic and foreign leading molecular diagnostics and production management personnel, led by the professional R&D team.

Inspired by our motto “Health Technologies • Healthy Life” HGT commits to high standard AFA product development. The unique AFA technology is dedicated to independent R&D and production of nucleic acid molecule detection products. The products comply with leading international standards for human ID and paternity identification, infectious pathogen detection, individualized medication guide and provides the most superior molecular detection solutions.

 

For more information, please visit

https://www.facebook.com/HealthGene

https://healthgenetech.wordpress.com/

https://twitter.com/HealthGeneTech

https://www.linkedin.com/company/health-gene-technologies-co-ltd

Advertisements


Leave a comment

Thermo Fisher Scientific Partners with HEALTH BioMed to Support Molecular Diagnostics Development in China

CARLSBAD, Calif., and NINGBO, China– AACC 2016 – (July 28, 2016) – Thermo Fisher Scientific, the world leader in serving science, and HEALTH BioMed (HBM) today announces a collaboration to support HBM’s development of molecular diagnostic (MDx) kits for infectious disease and pharmacogenomics screening to serve the China market.

Under the terms of a strategic agreement, HBM will submit all kits it develops on the Applied Biosystems 3500Dx Capillary Electrophoresis (CE) platform through the appropriate regulatory process with the China Food and Drug Administration (CFDA) following successful validation.

“Our collaboration with Thermo Fisher Scientific will enable HBM to meet a critical need in the China market for a series of high accuracy kits designed to run on a single CE platform to improve human health outcomes,” said Jianwei Yu, Chairman and CEO of HEALTH BioMed. “Molecular diagnostics such as these can improve diagnosis and treatment strategies in hospital settings while also helping to decrease antibiotic abuse.”

HBM intends to leverage its CE-based Advanced Fragment Analysis (AFA) technology and reagents, which are currently CE-IVD-and cFDA-marked as is the ABI 3500Dx platform, to develop multiple assays under its SureX brand of multiplex kits. HBM’s current offering for human papillomavirus (HPV)screening, for example,is designed to target 25 high- and low-risk markers with high sensitivity, specificity and low hands-on-time. Development of its pharmacogenomics kits under the agreement will be designed to further support precision medicine initiatives in the country.

“As the world leader in serving science, we are proud to be an enabling partner to help HEALTH BioMed build its portfolio of molecular diagnostics designed to better manage human health in China,” said Mark Smedley, president of genetic sciences at Thermo Fisher. “We are committed to working with diagnostic partners around the world who share our vision to drive the era of precision medicine.”

For more information, please visit Thermo Fisher (booths#2334 and #2145) or HEALTH BioMed (booth #2541) during the American Association for Clinical Chemistry (AACC) 2016 annual meeting July 31-Aug. 4 at the Pennsylvania Convention Center in Philadelphia.

 

About HEALTH BioMed and HEALTH Gene Technologies

Founded over 20 years, HEALTH BioMed (HBM) is a leading healthcare provider for clinical diagnostic and pharmaceutical products with business divisions of R&D, manufacture, sales and service for over 600 hospitals users in China.Guided by operation philosophy ‘Health Technologies, Healthier Services’, HBM dedicates to provide the world-class healthcare service and products to our customers.HEALTH Gene Technologies, HBM’s wholly-owned subsidiary, is committed to developing and manufacturing simple, rapid and effective nucleic acid testing solutions for partners in public safety and precisionmedicine. For more information, please visit HBM: www.nb-health.com/HGT.

 

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $17 billion and more than 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

 

Related Web Links:

Business Wire

genomeweb

 


Leave a comment

HGT can provide next day delivery to EU countries via its new established European logistics centre in the UK

2016-03-01

英国转站新闻稿 照片2

HEALTH Gene Technologies has seen a year of expansion in the overseas market. In order to service the expanding business in Europe, we have partnered with Shentong express (STO) British Co., Ltd. to build a strong logistics centre near the London Heathrow Airport. This UK cold storage warehouse has enabled HGT to provide most European customers with a next day delivery service.

From Q4 2015, all the shipments can be redirected to our customers from our brand new logistics spot to any country in Europe upon request. Most of the EU Zone countries will benefit from the next day delivery service and there will be no more customs clearance delay. This service will help HGT to develop its small and end user business in this region.

Located 10 minutes away from the London Heathrow Airport, HGT’s European logistics centre is equipped with advanced facilities and a professional team. Its online logistic system has seamless connection with delivery partners (DHL, TNT, Fedex, UPS), which enables the staff and customers to trace the packages closely.

STO Express is an experienced logistics company that specializes in logistics between China, Europe and worldwide, now equipped with cold storage capability for our molecular diagnostics products, they provide European customers with swift and convenient service.

STO Express UK:

Shentong express (STO) British Co., Ltd. is the British subsidiary of Shentong express, which was a subsidiary of A Plus Express Group more than 10 years. It is the official cooperation agency of ParcelForce, Bpost, DHL, UPS, Interlink, Yodel, Kangaroo, Countdown.

Shentong Express is the first delivery company to be listed in the Chinese Stock market. It is the biggest delivery private enterprise with more than 20 years of experience. It has the largest scale network within China and overseas, which consists of over 1400 subsidiaries, over 10,000 service spots, and over 200,000 staff members. In 2014, Shentong delivered 2.4 billion packages in total.

STO Express UK has fewer restrictions for mailing objects, and all couriers and freights are tracked via real-time technology. The company has conveniently settled its office and warehouse 10 minutes away from London Heathrow Airport. In order to accommodate the shipment of reagents via cold chain, STO express has established cold storage facilities and implemented professional management procedures.


About Health Gene Technologies

Health Gene Technologies founded in August 2011 is focused on gene analysis, molecular diagnostics product development, as well as the production and the sales of the products. HGT boasts 2,000 square meters of molecular diagnostics R&D laboratory and a 1,000 square metre GMP standard purification plant. It employs both domestic and foreign leading molecular diagnostics and production management personnel, led by the professional R&D team.

Inspired by our motto “Health Technologies • Healthy Life” HGT commits to high standard AFA product development. The unique AFA technology is dedicated to independent R&D and production of nucleic acid molecule detection products. The products comply with leading international standards for human ID and paternity identification, infectious pathogen detection, individualized medication guide and provides the most superior molecular detection solutions.


 

For more information, please visit

http://www.healthgenetech.com/


Leave a comment

HEALTH Gene Technologies visits the ARAB HEALTH and MEDLAB Middle East

2016-02-26

dav

ARAB HEALTH is one of the most actively rising healthcare exhibitions not only in the region but also in the world. As the World’s Largest Attended Laboratory Exhibition and Conference, MEDLAB Middle East – the dedicated IVD and laboratory section of Arab Health attracts a lot of visitors from different backgrounds and countries: the Middle East, Asia, Europe being the main sources of visitors. Thermo Fisher Scientific was exhibiting their 3500 Genetic Analyzer, which functions as a platform for all of HEALTH Gene Technologies products. This year boasted a large Chinese pavilion exhibiting the rising scene in the country.

arab health 1.jpg

Arab Health and MEDLAB Dubai exhibitions have recently become the meeting point for health care professionals in the industry as it is a showcase example of quality IVD and medical laboratory equipment, consumables and reagents.

We hope that the connections made will help us establish long-term cooperation within the region.


About Health Gene Technologies

Health Gene Technologies founded in August 2011 is focused on gene analysis, molecular diagnostics product development, as well as the production and the sales of the products. HGT boasts 2,000 square meters of molecular diagnostics R&D laboratory and a 1,000 square metre GMP standard purification plant. It employs both domestic and foreign leading molecular diagnostics and production management personnel, led by the professional R&D team.

Inspired by our motto “Health Technologies • Healthy Life” HGT commits to high standard AFA product development. The unique AFA technology is dedicated to independent R&D and production of nucleic acid molecule detection products. The products comply with leading international standards for human ID and paternity identification, infectious pathogen detection, individualized medication guide and provides the most superior molecular detection solutions.


 

For more information, please visit

http://www.healthgenetech.com/

 

 

 


Leave a comment

Health Gene Technologies took part in China-Russia official Chinese medicine partnership launch ceremony

中俄中医药全面合作启动仪式

On 29th May, 2015, a large and official launch ceremony on Russia and China Cooperation for Chinese Medicine took place in a prestigious Diaoyutai Hotel in Beijing, China.

Russian representatives visited Beijing in order to help set up a comprehensive trade plan, establish a trade agency and make a public announcement on the future actions.

Health Gene Technologies was also taking part in the ceremony, presenting their products and the innovative AFA technology based on CE

中俄中医药全面合作启动仪式 触摸球


About Health Gene Technologies

Health Gene Technologies founded in August 2011 is focused on gene analysis, molecular diagnostics product development, as well as the production and the sales of the products. HGT boasts 2,000 square meters of molecular diagnostics R&D laboratory and a 1,000 square metre GMP standard purification plant. It employs both domestic and foreign leading molecular diagnostics and production management personnel, led by the professional R&D team.

Inspired by our motto “Health Technologies • Healthy Life” HGT commits to high standard AFA product development. The unique AFA technology is dedicated to independent R&D and production of nucleic acid molecule detection products. The products comply with leading international standards for human ID and paternity identification, infectious pathogen detection, individualized medication guide and provides the most superior molecular detection solutions.


 

For more information, please visit:

http://www.healthgenetech.com/


Leave a comment

Health Gene Technologies Present at 3rdChina (Mianyang) Science & Technology City International High-Tech & Science Expo

4493823_四川绵阳科博会

The 3rd China (Mianyang) Science & Technology City International High-Tech & Science Expo was held in Mianyang, Sichuan, from September 17 to 20. The expo boasted a total exhibition area of 80,000 square meters with more than 800 exhibitors.

HEALTH Gene Technologies took part in this expo for the first time, supported by Ningbo Science and Technology Bureau, as a member of Ningbo Hi-Tech Enterprise delegation. Exhibitors from 47 countries and regions exhibited 8637 products cover 7 disciplines, such as electronic information and advanced manufacturing etc.

HEALTH Gene Technologies exhibited innovative and patented molecular diagnostic and forensic DNA reagents.


About Health Gene Technologies

Health Gene Technologies founded in August 2011 is focused on gene analysis, molecular diagnostics product development, as well as the production and the sales of the products. HGT boasts 2,000 square meters of molecular diagnostics R&D laboratory and a 1,000 square metre GMP standard purification plant. It employs both domestic and foreign leading molecular diagnostics and production management personnel, led by the professional R&D team.

Inspired by our motto “Health Technologies • Healthy Life” HGT commits to high standard AFA product development. The unique AFA technology is dedicated to independent R&D and production of nucleic acid molecule detection products. The products comply with leading international standards for human ID and paternity identification, infectious pathogen detection, individualized medication guide and provides the most superior molecular detection solutions.


For more information, please visit:

http://www.healthgenetech.com/